School of Medicine, Medical Sciences and Nutrition - University of Aberdeen

28/08/2026

We were delighted to welcome the Medical Class of 1991 back to campus for a weekend of reunion celebrations.

During their visit, the class enjoyed a tour of the Anatomy Department, where fourth-year medical students demonstrated some of the latest teaching technologies, including the Anatomage dissection table and virtual reality headsets.

The visit ended with a guided tour of the Cruickshank Botanic Garden 🪴.

26/08/2026

New research from the University of Aberdeen and Keele University has been the first to identify how s*x affects the relationship between cardiovascular disease (CVD) and cancer. To achieve this, they looked at data from over 20,000 people over a 25-year period to find out how the outcomes of people living with cardiovascular disease differed between the s*xes.

They found that males living with cardiovascular disease had a higher chance of developing cancer and subsequently dying from it than females. This was noticeable across all types of cancers, but most prominently in lung and oesophageal cancers.

Understanding these differences between males and females could help inform public health strategies, with the aim of achieving more equal health outcomes between the s*xes.

Read more ➡️ http://abdn.io/2nN

25/08/2026

Heavy menstrual bleeding affects one in three women in the UK. There are current treatments for heavy menstrual bleeding, but many are ineffective and come with side effects. As a result, a lot of women resort to surgery to remove the uterus, leading to infertility.

A new study funded by the National Institute for Health and Care Research (NIHR) which will be led jointly by Professors Siladitya Bhattacharya from the University of Aberdeen and Hilary Critchley from The University of Edinburgh will investigate whether a new medication called relugolix-CT could improve heavy menstrual bleeding in comparison to current treatment options through a clinical trial. Relugolix-CT is a daily pill which contains relugolix, which temporarily stops the menstrual cycle and contains hormone replacement therapy to prevent any menopausal symptoms from relugolix.

Previous research has been done using relugolix on women with fibroids, and it improved their symptoms significantly without some of the side effects associated with other treatments for heavy menstrual bleeding. Therefore, this treatment could provide a breakthrough for women experiencing heavy menstrual bleeding, offering a potential alternative to current treatment options and preserving fertility.

Read more ➡️

Researchers from the Universities of Aberdeen and Edinburgh have been awarded just under £2 million to lead a major clinical trial investigating a promising new treatment for heavy menstrual bleeding, which could transform the lives of millions of women around the world who live with the debilitati...

24/08/2026

🔬 Considering studying medicine or a medical science?

A reminder that we have an Undergraduate Open Day taking place tomorrow, Tuesday 25 August! Come along to explore our campus, meet current students and staff and find out what life at Aberdeen is really like.

Whether you already know what you want to study or are still exploring your options, we'll help you picture your future here.

🔗 Book your place today: abdn.ac.uk/openday

21/08/2026

🏆 Prestigious national award for University of Aberdeen and NHS Grampian team!

A team from Biostatistics and Health Data Science at the University of Aberdeen and NHS Grampian has won the Royal Statistical Society’s Florence Nightingale Award for Excellence in Health and Care Analytics.

Their research explored who is most affected by elective care waiting times and revealed significant inequalities, with people in the most deprived areas more likely to wait longer, attend A&E while waiting and experience greater healthcare needs.

The findings highlight how NHS data can help us better understand patient journeys, reduce health inequalities and identify people who may need additional support while waiting for care.

👏 Congratulations to everyone involved in this important work!

🔗 Read more: http://abdn.io/2mW

20/08/2026

🌱 To tackle climate and sustainability challenges in Scotland, Scotland Beyond Net Zero has funded three projects, each focusing on one of three key areas of net zero research: sustainable diets, renewable energy and the circular economy.

In the sustainable diets category, the funds are going to the project, ‘Fairness, Feasibility, and Acceptability of Diets-Free Transition Policies in Scotland.’ The research will be led by Dr David McBey of the The Rowett Institute, University of Aberdeen and Dr Stuart King of The University of Edinburgh. The project will examine how people across Scotland view potential policies to reduce consumption of red and processed meat, which are significant contributors to greenhouse gas emissions.

Read more ➡️ http://abdn.io/2mN

19/08/2026

BRCA mutations increase the likelihood of developing breast and ovarian cancer in women, and prostate and breast cancer in men. Previously, researchers across Scotland identified ancestral links to specific variants of this gene in people from Westray in Orkney and Whalsay in Shetland.

Now, eight charities across Scotland are funding a two-year project costing over £365,000, which will offer testing for specific BRCA variants to people with Westray and Whalsay ancestry using a simple saliva test. Friends of Anchor, a cancer and haematology charity based in North-east Scotland, will contribute £137,000 to the project.

By identifying people who carry these specific variants before getting cancer, the project will offer patients and their families access to genetic counselling, screening and preventative care.

The project is led by Professor Zosia Miedzybrodzka, Service Clinical Director of Genetics at NHS Grampian and Professor of Medical Genetics at the University of Aberdeen who was recently made an OBE for her services to genetic medicine and research.

Read more ➡️ http://abdn.io/2mG

17/08/2026

🧬 Could bowel cancer screening samples help unlock new health discoveries?

New research from the University of Aberdeen’s Rowett Institute has shown that surplus samples from Scotland’s NHS bowel cancer screening programme could be used to study the gut microbiota 🦠.

With around half a million samples collected each year, this could open the door to large-scale research into conditions including cardiovascular disease, diabetes, chronic inflammatory diseases and cancer.

🔬 A small sample today could help shape better understanding and treatments for tomorrow.

👉 Read more: http://abdn.io/2md

14/08/2026

Not one, not two but three celebrations! On 2 July, Charles Bain and his wife, Carol, had three reasons to celebrate. 🙌

1️⃣ Since 2011, Charles and Carol have made an outstanding contribution to dementia research, raising more than £235,000 for the University of Aberdeen. In recognition of his dedication, Charles was awarded an honorary degree from the university.

2️⃣ The couple celebrated their golden wedding anniversary, a milestone made even more special by the years they have spent working together to support dementia research.

3️⃣ Their fundraising has helped to fund PhD scholarships, extending the reach of the university’s work in dementia research even further. Olivia Soper completed her PhD in Neuroscience thanks to the funding.

Read more ➡️ http://abdn.io/2m5

13/08/2026

Good luck to everyone receiving their A-level results today. Our Clearing Hotline opens at 8:00am, so whether your results were not what you were hoping for - or you do much better than expected - call us on 01224 274525 or check out http://abdn.io/2lS to explore your opportunities or apply online for a quick decision today.